Skip to content

Laparoscopic Approach to Pyogenic Liver Abscess

Laproscopic Managment of Pyogenic Liver Abscess

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07303829
Enrollment
30
Registered
2025-12-26
Start date
2026-01-01
Completion date
2027-01-01
Last updated
2025-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Abscess, Pyogenic

Brief summary

Assess the efficacy and safety of laparoscopic management of liver abscess in achieving complete drainage and clinical recovery compared to conventional open or percutaneous methods, and to: 1. To evaluate postoperative complications and recurrence rates. 2. To compare hospital stay, recovery time, and overall morbidity. 3. To determine patient outcomes and cost-effectiveness of laparoscopic intervention.

Detailed description

Liver abscess is a localized collection of pus within the liver parenchyma, most commonly resulting from bacterial or amoebic infection. It remains a serious clinical condition requiring timely diagnosis and effective management to prevent complications such as sepsis or rupture. Traditionally, open surgical drainage was the standard treatment for complicated or multiloculated abscesses and in cases where percutaneous drainage failed. However, advances in minimally invasive surgery have introduced laparoscopic drainage as a safer and more efficient alternative. Laparoscopic management offers several advantages, including smaller incisions, reduced postoperative pain, shorter hospital stays, and faster recovery compared to open surgery. Moreover, it allows direct visualization of the abscess cavity, facilitates breaking of loculations, debridement of necrotic tissue, and precise placement of drainage catheters. These features enhance the completeness of drainage and reduce recurrence rates. Recent studies have demonstrated the efficacy of laparoscopic drainage, particularly in large, complex, or multiloculated liver abscesses where percutaneous methods are unsuccessful or contraindicated. A meta-analysis of 17 studies involving 608 patients reported a recurrence rate of only 4.22% with no procedure-related mortality in the laparoscopic group. Consequently, laparoscopic drainage is now considered a step-up approach in the management algorithm of liver abscess, bridging the gap between percutaneous and open surgical techniques, while ensuring optimal clinical outcomes and reduced morbidity.

Interventions

DEVICELaproscopic

Laparoscopic management uses minimally invasive trocar access with camera-guided drainage and debridement, allowing precise abscess evacuation, reduced tissue trauma, faster recovery, and lower postoperative pain compared with open surgery or percutaneous drainage used in other studies.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults ≥18 years. 2. Radiologically confirmed liver abscess (US/CT/MRI). 3. Abscess requiring drainage ≥5 cm, 4. Failed or contraindicated percutaneous drainage. 5. Recurrence after percutaneous drainage.

Exclusion criteria

1. Adults ≥18 years. 2. Radiologically confirmed liver abscess (US/CT/MRI). 3. Abscess requiring drainage ≥5 cm, 4. Failed or contraindicated percutaneous drainage. 5. Recurrence after percutaneous drainage.

Design outcomes

Primary

MeasureTime frameDescription
Major complication rate30 daysProcedure-related complications (Clavien-Dindo ≥ III) within 30 days.
Abscess recurrence6 months.Recurrence at the same or new site

Secondary

MeasureTime frameDescription
Technical success30daysSuccessful laparoscopic drainage and drain placement

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026